|
SYNTHES GMBH TFNA FENESTRATED HELICAL BLADE 95 - SILE; APPLIANCE, FIXATION, NAIL/BLADE/PLATE COMBINATION, MULTIPLE COMPONENT
|
Back to Search Results |
|
| Catalog Number |
04.038.395S |
| Medical Device Problem Code |
Device-Device Incompatibility (2919)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/05/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
Device report from synthes reports an event in japan as follows: it was reported that on (b)(6) 2024 the male patient underwent unknown surgery with tfna implant for trochanteric fracture.A blade was aimed to be inserted into bonehead beyond a guidewire, but the guidewire interfered with inside of the blade and the blade was unable to pass through.The guidewire itself seemed not to have flaw, and connecting the blade with an inserter was tried and checked, but there was no discovery for the cause.A decision was made for the blade planned to be inserted without guidewire.The blade was inserted eccentrically, and it was taken back, insertion move was retried as that condition, but the blade was unable to pass through the guidewire.Another blade was newly tried to be used for insertion and it passed through exactly the guidewire.Although total surgical time was scheduled to be 20 minutes, the surgery was completed successfully with an additional 45 minutes.After the surgery, the blade in question and the inserter was connected to check if it can pass through the guidewire, and it could not be inserted as the same time as unsuccessful situation, and next, each of device, the blade and the inserter were separately verified, accordingly a place in interference with the guidewire was turned out to be a connection part of inserter and the blade.The second blade successfully passed.This report is for one (1) tfna fenestrated helical blade 95 - sile.This is report 1 of 1 for complaint pc-(b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Product complaint # = > pc-(b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: d9: complainant part is expected to be returned for manufacturer review/investigation, but has yet to be received.H3, h4, h6: without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.D4: expiration date added.Lot number was reported as "3936p02 / 3793p48".Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.D10: concomitant device added.Date of concomitant therapy is (b)(6) 2024.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H6: a product investigation was conducted.The product was returned to depuy synthes for evaluation.The depuy synthes team conducted a visual inspection of the returned device.Visual analysis of the returned sample revealed that there was no damage or defects with the tfna fenestrated helical blade 95 - sile.A dimensional inspection was performed for the tfna fenestrated helical blade 95 - sile and met specifications.A functional test could not be performed as the mating device was not returned.The overall complaint was unconfirmed as the observed condition of the tfna fenestrated helical blade 95 - sile would not contribute to the complained device issue.There is no indication that a design or manufacturing issue has caused the complaint condition.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.H6: device history record (dhr) review conducted: manufacturing location: elmira / packaged, sterilized and released by: monument manufacturing date: 25-jan-2023 expiration date: 01-jan-2033 part number: 04.038.395s, tfna fenestrated helical blade 95mm -sterile lot number: 3936p02 (sterile) lot quantity: (b)(4) note: helical blade was manufactured by elmira; lot numbers 3793p48 quantity (b)(4) and 3770p94 quantity (b)(4).Parts were packaged, sterilized and released by monument.Production order traveler met all inspection acceptance criteria.Packaging label log (pll) lmd rev ac was reviewed and determined to be conforming.Packaging bom was reviewed and determined to be conforming with no deviations to normal packaging identified.Scn was reviewed and determined to be conforming.This lot met all visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.This lot met all sterility and packaging criteria at the time of release with no issues documented during the sterilization or release of the product that would contribute to this complaint condition.Packaging bom was reviewed and determined to be conforming with no deviations to normal packaging identified.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H6: product investigation updated: the product was returned to depuy synthes for evaluation.The depuy synthes team forwarded the device to elmira which conducted a visual inspection of the returned device.The received part showed cosmetic signs of handling consistent with implantation / extraction process consisting of light scratches to the surface.A dimensional inspection was performed for the tfna fenestrated helical blade 95 - sile and met specifications.A functional test could not be performed as the mating device was not returned.The manufacturing investigation determined the complaint condition is not confirmed.No manufacturing related issues were identified and/or confirmed.The overall complaint was unconfirmed as the observed condition of the tfna fenestrated helical blade 95 - sile would not contribute to the complained device issue.There is no indication that a design or manufacturing issue has caused the complaint condition.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H11 additional narrative: h6 component codes: most relevant component code is g07002 (appropriate term/code not available) to capture no findings available due to no product returned.H3, h6: the product was returned to depuy synthes for evaluation.The depuy synthes team forwarded the device to elmira which conducted a visual inspection of the returned device.The received part showed cosmetic signs of handling consistent with implantation consisting of light scratches to the surface finish on both inside and outside features.The above features relating to the potential misalignment of the cannulation with the mating instruments were measured with the gaging used at jabil elmira during the processing of the 04.038m395sp tfna fenestrated helical blades.The manufacturing investigation determined the complaint condition is not confirmed as all features were found conforming.No manufacturing related issues were identified and/or confirmed, therefore review to the specific prm and prm line is not applicable.The manufacturing investigation determined the complaint condition is not confirmed.No manufacturing related issues were identified and/or confirmed.The overall complaint was unconfirmed as the observed condition of the tfna fenestrated helical blade 95 - sile would not contribute to the complained device issue.There is no indication that a design or manufacturing issue has caused the complaint condition.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.Device history lot: manufacturing location: elmira / packaged, sterilized and released by: monument.Manufacturing date: 25-jan-2023.Expiration date: 01-jan-2033.Part number: 04.038.395s, tfna fenestrated helical blade 95mm -sterile.Lot number: 3936p02 (sterile).Lot quantity: 94.Note: helical blade was manufactured by elmira; lot numbers 3793p48 quantity 48 and 3770p94 quantity 46.Parts were packaged, sterilized and released by monument.Production order traveler met all inspection acceptance criteria.Packaging label log (pll) lmd rev ac was reviewed and determined to be conforming.Packaging bom was reviewed and determined to be conforming with no deviations to normal packaging identified.Scn 24446 supplied by sterigenics was reviewed and determined to be conforming.This lot met all visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Device history review: this lot met all sterility and packaging criteria at the time of release with no issues documented during the sterilization or release of the product that would contribute to this complaint condition.Packaging bom was reviewed and determined to be conforming with no deviations to normal packaging identified.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Search Alerts/Recalls
|
|
|